Oxford, United Kingdom

Alan Hastings Drummond

This inventor holds 4 USPTO granted patents. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan Hastings Drummond. Retrieved from https://idiyas.com/inventor/alan-hastings-drummond-em667vrr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Alan Hastings Drummond: Innovator in Cytostatic Agents

Introduction

Alan Hastings Drummond is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cytostatic agents. With a total of 4 patents to his name, Drummond's work has had a meaningful impact on medical science.

Latest Patents

Drummond's latest patents focus on cytostatic agents, which are crucial in the treatment of various cancers. These agents play a vital role in inhibiting cell growth and division, thereby providing therapeutic benefits to patients undergoing cancer treatment.

Career Highlights

Drummond is currently associated with British Biotech Pharmaceuticals Limited, where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has positioned him as a key player in the industry, contributing to advancements that enhance patient care.

Collaborations

Throughout his career, Drummond has collaborated with esteemed colleagues, including Andrew Paul Ayscough and Lindsey Ann Pearson. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alan Hastings Drummond's contributions to the field of cytostatic agents exemplify his dedication to improving medical treatments. His work continues to inspire future innovations in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…